Variant report
Variant | esv3405117 |
---|---|
Chromosome Location | chr4:94224879-94226127 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112544545 | chr4:94224884-94224885 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs151284691 | chr4:94224893-94224894 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564566221 | chr4:94224900-94224901 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535623124 | chr4:94224936-94224937 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555534956 | chr4:94224951-94224952 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575445324 | chr4:94224966-94224967 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs80012407 | chr4:94224987-94224988 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs143254153 | chr4:94224992-94224993 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577529661 | chr4:94224998-94224999 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540208488 | chr4:94225011-94225012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190874535 | chr4:94225017-94225018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs79579076 | chr4:94225035-94225036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182731365 | chr4:94225081-94225082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375044711 | chr4:94225115-94225116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs75863625 | chr4:94225170-94225171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs531558604 | chr4:94225249-94225250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs114633691 | chr4:94225294-94225295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146700125 | chr4:94225333-94225334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192056111 | chr4:94225347-94225348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570434075 | chr4:94225359-94225360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11324322 | chr4:94225368-94225369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs397994539 | chr4:94225374-94225375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs145476183 | chr4:94225409-94225410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34224208 | chr4:94225420-94225421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs59940813 | chr4:94225426-94225427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs397994540 | chr4:94225429-94225430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs62307805 | chr4:94225499-94225500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs182829584 | chr4:94225507-94225508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535518710 | chr4:94225545-94225546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373537696 | chr4:94225547-94225548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs59578568 | chr4:94225585-94225586 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs538062099 | chr4:94225590-94225591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557962236 | chr4:94225605-94225606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs187253165 | chr4:94225660-94225661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540616262 | chr4:94225670-94225671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77608698 | chr4:94225684-94225685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs573565532 | chr4:94225745-94225746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542698147 | chr4:94225791-94225792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs200566935 | chr4:94225795-94225796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs562587732 | chr4:94225813-94225814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149184795 | chr4:94225852-94225853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs35397640 | chr4:94225865-94225866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577436552 | chr4:94225883-94225884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs564980664 | chr4:94225884-94225885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs376747258 | chr4:94225889-94225890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560504936 | chr4:94225908-94225909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528087591 | chr4:94225917-94225918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547386800 | chr4:94225953-94225954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570090702 | chr4:94225985-94225986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192182595 | chr4:94226005-94226006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 20841430 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Epilepsy | 20502679 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:94220600-94226400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr4:94221200-94225000 | Enhancers | HMEC | breast |
3 | chr4:94222000-94228400 | Weak transcription | Primary hematopoietic stem cells | blood |
4 | chr4:94224400-94225000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |